Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Total Liabilities 2009–2025
Protalix Biotherapeutics Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Protalix Biotherapeutics Inc. total liabilities as of December 31, 2025: 34.1M, a 12.94% increase year-over-year.
- Protalix Biotherapeutics Inc. total liabilities for 2025 were 34.1M, a 12.94% increase from 2024.
- Protalix Biotherapeutics Inc. total liabilities for 2024 were 30.2M, a 40.62% decrease from 2023.
- Protalix Biotherapeutics Inc. total liabilities for 2023 were 50.9M, a 23.43% decrease from 2022.
- Protalix Biotherapeutics Inc. total liabilities for 2022 were 66.4M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Protalix Biotherapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $34 |
| 2024 | $30 |
| 2023 | $51 |
| 2022 | $66 |
| 2021 | $80 |
| 2020 | $95 |
| 2019 | $116 |
| 2018 | $114 |
| 2017 | $102 |
| 2016 | $92 |
| 2015 | $86 |
| 2014 | $134 |
| 2013 | $140 |
| 2012 | $82 |
| 2011 | $78 |
Protalix Biotherapeutics Inc. Total Liabilities — FAQ
Protalix Biotherapeutics Inc. (PLX) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's total liabilities history?
The chart and table above show Protalix Biotherapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.